Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis Neuro Central, 24 Jan 2022 WILMINGTON, Del.--(BUSINESS WIRE)--Eplontersen has been granted Orphan Drug Designation (ODD) in the US by the Food and Drug…